Clinical Trial Update: EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer [NA]

View source ↗

Summary

This entry notes an ongoing clinical trial (EUFURO, NCT02209415) evaluating EUS-based follow-up for patients with R0-resected esophageal, gastric, and pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer

Snippet

Sponsor: Michael Bau Mortensen | Conditions: Esophageal Cancer, Stomach Cancer | NA | Status: UNKNOWN